132 related articles for article (PubMed ID: 1737378)
41. Mode of action of estra-1,3,5(10)-triene-3,17 beta-diol 3-benzoate 17-[4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)acet ate) on human breast carcinoma xenografts in nude mice.
Kubota T; Koh J; Yamada Y; Oka S; Enomoto K; Ishibiki K; Abe O; Masui O; Asano K
Jpn J Cancer Res; 1988 Nov; 79(11):1224-9. PubMed ID: 3147278
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.
Shiba E; Kim SJ; Kambayashi J; Kawamura I; Lacey E; Manda T; Shimomura K; Taguchi T; Takai S
Anticancer Res; 1997; 17(3C):1919-23. PubMed ID: 9216645
[TBL] [Abstract][Full Text] [Related]
43. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells.
Serrero G; Lu R
Antioxid Redox Signal; 2001 Dec; 3(6):969-79. PubMed ID: 11813992
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effects of bestrabucil, a conjugate of chlorambucil and estradiol, on the production of androgen-induced growth factor(s) by Shionogi carcinoma 115 cells.
Akaza H; Imada S; Tsukamoto S; Koiso K
Int J Urol; 1994 Mar; 1(1):67-73. PubMed ID: 7627841
[TBL] [Abstract][Full Text] [Related]
45. Influence of phomopsin and ivalin on steroid-hormone binding and growth of MCF-7 human breast cancer cells.
van Aswegen CH; Lewko WM; Wittliff JL
J Toxicol Environ Health; 1985; 16(1):13-23. PubMed ID: 4068051
[TBL] [Abstract][Full Text] [Related]
46. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
James SY; Mackay AG; Binderup L; Colston KW
J Endocrinol; 1994 Jun; 141(3):555-63. PubMed ID: 8071654
[TBL] [Abstract][Full Text] [Related]
47. Internalization of a C17α-alkynylestradiol-porphyrin conjugate into estrogen receptor positive MCF-7 breast cancer cells.
Sadler S; Persons KS; Jones GB; Ray R
Bioorg Med Chem Lett; 2011 Aug; 21(15):4638-41. PubMed ID: 21704522
[TBL] [Abstract][Full Text] [Related]
48. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
Murphy LC; Sutherland RL
J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
[TBL] [Abstract][Full Text] [Related]
49. The effects of TGF-alpha and 17 beta-estradiol on polyphosphoinositide metabolism in MCF-7 breast cancer cells.
Etindi RN; Manni A; Martel J
Breast Cancer Res Treat; 1992; 24(1):61-70. PubMed ID: 1334440
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the antitumor activity of two triarylcyclopropyl antiestrogens (compounds 4d and 5c) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Drugs; 1994 Aug; 5(4):429-36. PubMed ID: 7949247
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of D- and L-tyrosine-chlorambucil analogs active against breast cancer cell lines.
Descôteaux C; Leblanc V; Brasseur K; Gupta A; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2010 Dec; 20(24):7388-92. PubMed ID: 21051231
[TBL] [Abstract][Full Text] [Related]
52. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro.
Fioravanti L; Cappelletti V; Miodini P; Ronchi E; Brivio M; Di Fronzo G
Cancer Lett; 1998 Aug; 130(1-2):143-52. PubMed ID: 9751267
[TBL] [Abstract][Full Text] [Related]
53. Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast cancer cells.
Freter CE; Lippman ME; Cheville A; Zinn S; Gelmann EP
Mol Endocrinol; 1988 Feb; 2(2):159-66. PubMed ID: 2840572
[TBL] [Abstract][Full Text] [Related]
54. Antiproliferative activity of a series of novel cyclopropyl antiestrogens on MCF-7 human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA; Graves DC
Anticancer Drugs; 1991 Oct; 2(5):487-93. PubMed ID: 1804391
[TBL] [Abstract][Full Text] [Related]
55. Specific cytotoxicity of 16 alpha-[125I]iodoestradiol for estrogen receptor-containing breast cancer cells.
Bronzert DA; Hochberg RB; Lippman ME
Endocrinology; 1982 Jun; 110(6):2177-82. PubMed ID: 7075553
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.
So FV; Guthrie N; Chambers AF; Carroll KK
Cancer Lett; 1997 Jan; 112(2):127-33. PubMed ID: 9066718
[TBL] [Abstract][Full Text] [Related]
57. Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer.
McClelland RA; Gee JM; Francis AB; Robertson JF; Blamey RW; Wakeling AE; Nicholson RI
Eur J Cancer; 1996 Mar; 32A(3):413-6. PubMed ID: 8814683
[TBL] [Abstract][Full Text] [Related]
58. SAR study of tyrosine-chlorambucil hybrid regioisomers; synthesis and biological evaluation against breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Amino Acids; 2012 Aug; 43(2):923-35. PubMed ID: 22102055
[TBL] [Abstract][Full Text] [Related]
59. Estrogen inhibits the growth of MCF-7 cell variants resistant to transforming growth factor-beta.
Hagino Y; Mawatari M; Yoshimura A; Kohno K; Kobayashi M; Kuwano M
Jpn J Cancer Res; 1988 Jan; 79(1):74-81. PubMed ID: 3128508
[TBL] [Abstract][Full Text] [Related]
60. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation.
Falany JL; Macrina N; Falany CN
Breast Cancer Res Treat; 2002 Jul; 74(2):167-76. PubMed ID: 12186377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
